Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


5 dead, more than 80 missing after Philippine ferry fire
US military says it struck vessel in Caribbean, killing 3
At least 14 killed in explosion at weapons depot in Syria
US hits five Iranian oil tankers after attack on Navy ships
UK gives air traffic provider a week to probe outage that halted flights
Serbia's President Vucic dissolves parliament, calls snap elections
With large crowds attending, Norway lays King Harald to rest
Jordan intercepts 18 Iranian ballistic missiles
